Rontis Corporation S.A. (Zug, Switzerland) announces the conclusion of pre-clinical tests on a new drug-coated balloon (DCB). The DCB tested is based on the Cronus® family of PTA OTW (0.035”) balloon dilatation catheters, which have been in the market since year 2010 and are worldwide recognized for their flexibility, combined with the high pressures they can achieve.
